DexCom Announces Upcoming Conference Presentation

Go back to DexCom Announces Upcoming Conference Presentation

DexCom (DXCM) PT Lowered to $92 at Oppenheimer Following 2Q

August 2, 2017 9:36 AM EDT

Oppenheimer lowered its price target on DexCom (NASDAQ: DXCM) to $92.00 (from $98.00) while maintaining a Outperform rating. 2Q17 revenue of $170.6M was ahead of the consensus estimate of $166.6M. The beat was both in the US and international. US sales were ~$140.8M, above... More